Key insights
- Wellgistics Health (WGRX) announced a lock-up agreement with holders of a majority of its common stock, preventing the sale of 1,333,930 shares for at least 90 days. While this signals shareholder confidence, the impact on the broader US equity market is slightly negative, suggesting reduced liquidity and potential downward pressure on the stock price in the short term.
Holders of 1,333,930 common shares agree to minimum 90-day lock-up agreement
Wellgistics Health, Inc. ("Wellgistics") (NASDAQ: WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that holders of a 1,333,930 common shares, representing a majority of the outstanding common shares of the Company, have entered into a lock-up agreement that precludes the sale of their shares into the market for at least 90 days.
"This lock-up agreement, when combined with the recent restructuring of our convertible liabilities and the raising of new funding, underscores the confidence our shareholders have in management to execute against our recently-disclosed vertically-integrated growth plan outlined in the Company's recent shareholder letter," said Wellgistics Health Interim Co-CEO Gerald Commissiong. "We believe we will achieve important milestones against our execution plan in the weeks and months ahead. We look forward to updating the market as we make progress in achieving such milestones."